These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27412010)

  • 1. Molecular disturbance underlies to arrhythmogenic cardiomyopathy induced by transgene content, age and exercise in a truncated PKP2 mouse model.
    Moncayo-Arlandi J; Guasch E; Sanz-de la Garza M; Casado M; Garcia NA; Mont L; Sitges M; Knöll R; Buyandelger B; Campuzano O; Diez-Juan A; Brugada R
    Hum Mol Genet; 2016 Sep; 25(17):3676-3688. PubMed ID: 27412010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive Reduction in Right Ventricular Contractile Function Attributable to Altered Actin Expression in an Aging Mouse Model of Arrhythmogenic Cardiomyopathy.
    Camors EM; Roth AH; Alef JR; Sullivan RD; Johnson JN; Purevjav E; Towbin JA
    Circulation; 2022 May; 145(21):1609-1624. PubMed ID: 35437032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2.
    Cruz FM; Sanz-Rosa D; Roche-Molina M; García-Prieto J; García-Ruiz JM; Pizarro G; Jiménez-Borreguero LJ; Torres M; Bernad A; Ruíz-Cabello J; Fuster V; Ibáñez B; Bernal JA
    J Am Coll Cardiol; 2015 Apr; 65(14):1438-50. PubMed ID: 25857910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of Ca
    Kim JC; Pérez-Hernández M; Alvarado FJ; Maurya SR; Montnach J; Yin Y; Zhang M; Lin X; Vasquez C; Heguy A; Liang FX; Woo SH; Morley GE; Rothenberg E; Lundby A; Valdivia HH; Cerrone M; Delmar M
    Circulation; 2019 Sep; 140(12):1015-1030. PubMed ID: 31315456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium current deficit and arrhythmogenesis in a murine model of plakophilin-2 haploinsufficiency.
    Cerrone M; Noorman M; Lin X; Chkourko H; Liang FX; van der Nagel R; Hund T; Birchmeier W; Mohler P; van Veen TA; van Rijen HV; Delmar M
    Cardiovasc Res; 2012 Sep; 95(4):460-8. PubMed ID: 22764151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Truncating plakophilin-2 mutations in arrhythmogenic cardiomyopathy are associated with protein haploinsufficiency in both myocardium and epidermis.
    Rasmussen TB; Nissen PH; Palmfeldt J; Gehmlich K; Dalager S; Jensen UB; Kim WY; Heickendorff L; Mølgaard H; Jensen HK; Baandrup UT; Bross P; Mogensen J
    Circ Cardiovasc Genet; 2014 Jun; 7(3):230-40. PubMed ID: 24704780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Dalal D; James C; Devanagondi R; Tichnell C; Tucker A; Prakasa K; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    J Am Coll Cardiol; 2006 Oct; 48(7):1416-24. PubMed ID: 17010805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYH10 activation rescues contractile defects in arrhythmogenic cardiomyopathy (ACM).
    García-Quintáns N; Sacristán S; Márquez-López C; Sánchez-Ramos C; Martinez-de-Benito F; Siniscalco D; González-Guerra A; Camafeita E; Roche-Molina M; Lytvyn M; Morera D; Guillen MI; Sanguino MA; Sanz-Rosa D; Martín-Pérez D; Garcia R; Bernal JA
    Nat Commun; 2023 Oct; 14(1):6461. PubMed ID: 37833253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAV-Mediated Delivery of Plakophilin-2a Arrests Progression of Arrhythmogenic Right Ventricular Cardiomyopathy in Murine Hearts: Preclinical Evidence Supporting Gene Therapy in Humans.
    van Opbergen CJM; Narayanan B; Sacramento CB; Stiles KM; Mishra V; Frenk E; Ricks D; Chen G; Zhang M; Yarabe P; Schwartz J; Delmar M; Herzog CD; Cerrone M
    Circ Genom Precis Med; 2024 Feb; 17(1):e004305. PubMed ID: 38288614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
    Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
    Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family.
    Kannankeril PJ; Bhuiyan ZA; Darbar D; Mannens MM; Wilde AA; Roden DM
    Heart Rhythm; 2006 Aug; 3(8):939-44. PubMed ID: 16876743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the molecular phenotype of two arrhythmogenic right ventricular cardiomyopathy (ARVC)-related plakophilin-2 (PKP2) mutations.
    Joshi-Mukherjee R; Coombs W; Musa H; Oxford E; Taffet S; Delmar M
    Heart Rhythm; 2008 Dec; 5(12):1715-23. PubMed ID: 19084810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy.
    Sommariva E; Brambilla S; Carbucicchio C; Gambini E; Meraviglia V; Dello Russo A; Farina FM; Casella M; Catto V; Pontone G; Chiesa M; Stadiotti I; Cogliati E; Paolin A; Ouali Alami N; Preziuso C; d'Amati G; Colombo GI; Rossini A; Capogrossi MC; Tondo C; Pompilio G
    Eur Heart J; 2016 Jun; 37(23):1835-46. PubMed ID: 26590176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
    Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plakophilin-2 missense mutations in arrhythmogenic right ventricular cardiomyopathy.
    Lahtinen AM; Lehtonen A; Kaartinen M; Toivonen L; Swan H; Widén E; Lehtonen E; Lehto VP; Kontula K
    Int J Cardiol; 2008 May; 126(1):92-100. PubMed ID: 17521752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2.
    Dalal D; Molin LH; Piccini J; Tichnell C; James C; Bomma C; Prakasa K; Towbin JA; Marcus FI; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    Circulation; 2006 Apr; 113(13):1641-9. PubMed ID: 16549640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of two edited iPSCs lines by CRISPR/Cas9 with point mutations in PKP2 gene for arrhythmogenic cardiomyopathy in vitro modeling.
    Amin G; Castañeda SL; Zabalegui F; Belli C; Atorrasagasti C; Miriuka SG; Moro LN
    Stem Cell Res; 2023 Sep; 71():103157. PubMed ID: 37393721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.
    Kim C; Wong J; Wen J; Wang S; Wang C; Spiering S; Kan NG; Forcales S; Puri PL; Leone TC; Marine JE; Calkins H; Kelly DP; Judge DP; Chen HS
    Nature; 2013 Feb; 494(7435):105-10. PubMed ID: 23354045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis.
    Antoniades L; Tsatsopoulou A; Anastasakis A; Syrris P; Asimaki A; Panagiotakos D; Zambartas C; Stefanadis C; McKenna WJ; Protonotarios N
    Eur Heart J; 2006 Sep; 27(18):2208-16. PubMed ID: 16893920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study.
    Cerrone M; Marrón-Liñares GM; van Opbergen CJM; Costa S; Bourfiss M; Pérez-Hernández M; Schlamp F; Sanchis-Gomar F; Malkani K; Drenkova K; Zhang M; Lin X; Heguy A; Velthuis BK; Prakken NHJ; LaGerche A; Calkins H; James CA; Te Riele ASJM; Delmar M
    Eur Heart J; 2022 Mar; 43(12):1251-1264. PubMed ID: 34932122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.